Discovery of functional non-coding conserved regions in the α-synuclein gene locus

F1000Research

Volumn 3, Issue , 2014, Pages

  Schüle, Birgitt ^a   Sterling, Lori ^a   Walter, Michael ^b   Ting, Dennis ^a  

^a PARKINSON S INSTITUTE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PITX3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CELL SURVIVAL; DNA SEQUENCE; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; GENE LOCUS; INTRON; MESENCEPHALON; MOUSE; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SNCA GENE; TRANSCRIPTION REGULATION;

EID: 84923166558     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.3281.2     Document Type: Article

References (45)

1. Cookson MR: alpha-Synuclein and neuronal cell death. Mol Neurodegener. 2009;4:9. 19193223 10.1186/1750-1326-4-9 2646729
2. Farrer M Kachergus J Forno L: Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol. 2004;55(2):174-179. 14755720 10.1002/ana.10846
3. Singleton AB Farrer M Johnson J: alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302(5646):841. 14593171 10.1126/science.1090278
4. Chartier-Harlin MC Kachergus J Roumier C: Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet. 2004;364(9440):1167-1169. 15451224 10.1016/S0140-6736(04)17103-1
5. Zarranz JJ Alegre J Gomez-Esteban JC: The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164-173. 14755719 10.1002/ana.10795
6. Polymeropoulos MH Lavedan C Leroy E: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276(5321):2045-2047. 9197268 10.1126/science.276.5321.2045
7. Krüger R Kuhn W Muller T: Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18(2):106-108. 9462735 10.1038/ng0298-106
8. Nishioka K Hayashi S Farrer MJ: Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol. 2006;59(2):298-309. 16358335 10.1002/ana.20753
9. Ibanez P Bonnet AM Debarges B: Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet. 2004;364(9440):1169-1171. 15451225 10.1016/S0140-6736(04)17104-3
10. Fuchs J Nilsson C Kachergus J: Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology. 2007;68(12):916-922. 17251522 10.1212/01.wnl.0000254458.17630.c5
11. Farrer M Maraganore DM Lockhart P: alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet. 2001;10(7):1847-1851. 11532993 10.1093/hmg/10.17.1847
12. Holzmann C Kruger R Saecker AM: Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease. J Neural Transm. 2003;110(1):67-76. 12541013
13. Wang CK Chen CM Chang CY: alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease. J Neural Transm. 2006;113(10):1425-1433. 16604306 10.1007/s00702-006-0435-4
14. Chiba-Falek O Nussbaum RL: Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet. 2001;10(26):3101-3109. 11751692 10.1093/hmg/10.26.3101
15. Chiba-Falek O Touchman JW Nussbaum RL: Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet. 2003;113(5):426-431. 12923682 10.1007/s00439-003-1002-9
16. Chiba-Falek O Kowalak JA Smulson ME: Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am J Hum Genet. 2005;76(3):478-492. 15672325 10.1086/428655 1196399
17. Mizuta I Satake W Nakabayashi Y: Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Genet. 2006;15(7):1151-1158. 16500997 10.1093/hmg/ddl030
18. Pals P Lincoln S Manning J: alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol. 2004;56(4):591-595. 15455394 10.1002/ana.20268
19. Maraganore DM de Andrade M Elbaz A: Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006;296(6):661-670. 16896109 10.1001/jama.296.6.661
20. Cronin KD Ge D Manninger P: Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum Mol Genet. 2009;18(17):3274-3285. 19498036 10.1093/hmg/ddp265 2722989
21. Linnertz C Saucier L Ge D: Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS One. 2009;4(10):e7480. 19834617 10.1371/journal.pone.0007480 2759540
22. Clough RL Dermentzaki G Stefanis L: Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219. J Neurochem. 2009;110(5):1479-1490. 19549071 10.1111/j.1471-4159.2009.06250.x
23. Clough RL Dermentzaki G Haritou M: Regulation of α-synuclein expression in cultured cortical neurons. J Neurochem. 2011;117(2):275-285. 21272005 10.1111/j.1471-4159.2011.07199.x
24. Clough RL Stefanis L: A novel pathway for transcriptional regulation of alpha-synuclein. FASEB J. 2007;21(2):596-607. 17167067 10.1096/fj.06-7111com
25. Touchman JW Dehejia A Chiba-Falek O: Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. Genome Res. 2001;11(1):78-86. 11156617 311023
26. Scherzer CR Grass JA Liao Z: GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc Natl Acad Sci U S A. 2008;105(31):10907-10912. 18669654 10.1073/pnas.0802437105 2504800
27. Sadee W Hartmann K Seweryn M: Missing heritability of common diseases and treatments outside the protein-coding exome. Hum Genet. 2014;133(10):1199-125. 25107510 10.1007/s00439-014-1476-7 4169001
28. Loots GG Locksley RM Blankespoor CM: Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science. 2000;288(5463):136-140. 10753117 10.1126/science.288.5463.136
29. Dubchak I Brudno M Loots GG: Active conservation of noncoding sequences revealed by three-way species comparisons. Genome Res. 2000;10(9):1304-1306. 10984448 10.1101/gr.142200 310906
30. Cartharius K Frech K Grote K: MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 2005;21(13):2933-2942. 15860560 10.1093/bioinformatics/bti473
31. Nunes I Tovmasian LT Silva RM: Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci U S A. 2003;100(7):4245-4250. 12655058 10.1073/pnas.0230529100 153078
32. Vernay B Koch M Vaccarino F: Otx2 regulates subtype specification and neurogenesis in the midbrain. J Neurosci. 2005;25(19):4856-4867. 15888661 10.1523/JNEUROSCI.5158-04.2005
33. Kim J Inoue K Ishii J: A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317(5842):1220-1224. 17761882 10.1126/science.1140481 2782470
34. Fuchs J Mueller JC Lichtner P: The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiol Aging. 2009;30(5):731-738. 17905480 10.1016/j.neurobiolaging.2007.08.014
35. Morale MC Serra PA Delogu MR: Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide. FASEB J. 2004;18(1):164-166. 14630699 10.1096/fj.03-0501fje
36. Giasson BI Duda JE Murray IV: Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000;290(5493):985-989. 11062131 10.1126/science.290.5493.985
37. Fujiwara H Hasegawa M Dohmae N: alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160-164. 11813001 10.1038/ncb748
38. Liu J Francke U: Identification of cis-regulatory elements for MECP2 expression. Hum Mol Genet. 2006;15(11):1769-1782. 16613900 10.1093/hmg/ddl099
39. Marlin S Blanchard S Slim R: Townes-Brocks syndrome: detection of a SALL1 mutation hot spot and evidence for a position effect in one patient. Hum Mutat. 1999;14(5):377-386. 10533063 10.1002/(SICI)1098-1004(199911)14:5&<377::AID-HUMU3&>3.0.CO;2-A
40. Lettice LA Heaney SJ Purdie, LA: A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet. 2003;12(14):1725-1735. 12837695 10.1093/hmg/ddg180
41. Grice EA Rochelle ES Green ED: Evaluation of the RET regulatory landscape reveals the biological relevance of a HSCR-implicated enhancer. Hum Mol Genet. 2005;14(24):3837-3845. 16269442 10.1093/hmg/ddi408
42. Prakash N Wurst W: Development of dopaminergic neurons in the mammalian brain. Cell Mol Life Sci. 2006;63(2):187-206. 16389456 10.1007/s00018-005-5387-6
43. Ang SL: Transcriptional control of midbrain dopaminergic neuron development. Development. 2006;133(18):3499-3506. 16899537 10.1242/dev.02501
44. Kittappa R Chang WW Awatramani RB: The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol. 2007;5(12):e325. 18076286 10.1371/journal.pbio.0050325 2121110
45. Sterling L Walter M Ting D: Combined normalized raw datasets of Luciferase assays on SNCA conserved elements. F1000Research. 2014. Data Source